87 results
8-K
EX-1.1
NAVB
Navidea Biopharmaceuticals, Inc.
17 Jun 19
Navidea Biopharmaceuticals Announces Proposed Public Offering of Common Stock
10:00am
, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, “dear
424B5
afu1vj chuban7065v4
24 Sep 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
tc0wc5m5h737e py9q
12 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
xpb5e
22 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.1
fgfuhvnt
28 Jun 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jhpo3hux
16 May 13
Entry into a Material Definitive Agreement
12:00am
424B5
2i3rrqofqmcr05
24 Apr 13
Prospectus supplement for primary offering
12:00am
424B5
vtjpkw
31 Jan 13
Prospectus supplement for primary offering
12:00am
424B3
jw3 mpphcwadnep
31 Dec 12
Prospectus supplement
12:00am
8-K/A
EX-10.1
85uwx2 6i4bb
11 Apr 12
Entry into a Material Definitive Agreement
12:00am